A $20 Billion Industry

The growing Biologic Infusion market
The Biologic Infusion Market is estimated at $20BN+

  • Growing drug pipeline: Over 30+ target market drugs in stage 3 of clinical trials
  • Increased patient diagnosis: Advancement in medical understanding and diagnosis of targeted conditions (i.e. MS, arthritis, etc.) continues to expand market opportunity
  • Effective treatments leading to longer patient life: Proven success of biologics as the most effective treatment option extends patient’s quality of life and further expands market

Specialty Treatments and Therapies

Reach a diversified customer base.
Ability to service specialty patients across several medical therapies, not just one segment of patients:

  • Rheumatology
  • Neurology
  • Immunology
  • Gastrology

A Safe Investment That’s Recession Resistant

  • Our care is a priority.
    Healthcare is considered highly recession-proof as patients will always need care and prioritize it above other needs.
  • Limited Competition
    Our model is unique. Market is emerging, fragmented, with no single competitor with dominant market share.
  • Low Capex
    Opening new sites requires minimal capital investment
  • Strong Site Financials
    Highly profitable site economics.

Locations

We have multiple centers in the Tampa Bay Area, all conveniently located near major hospitals with plenty of parking.

Tampa

Hours (by appointment):

Monday – Thursday 7am-8pm
Friday  7am-5pm
Saturday 8am-6pm

Clearwater

Hours (by appointment):

Monday – Thursday 7am-8pm
Friday  7am-5pm
Saturday 8am-6pm